C Wang

769 total citations
39 papers, 553 citations indexed

About

C Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, C Wang has authored 39 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in C Wang's work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). C Wang is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). C Wang collaborates with scholars based in China, United States and Australia. C Wang's co-authors include Rutai Hui, Lei Song, Yang Zou, L Zhang, Ming Su, Xin‐Cun Wang, Weijie Dong, Wei Qiu, Yibo Wang and Jianwei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

C Wang

31 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Wang China	13	267	163	153	88	66	39	553
Natasja Kisters Netherlands	6	276 1.0×	84 0.5×	202 1.3×	129 1.5×	55 0.8×	7	578
Heike Meýborg Germany	16	233 0.9×	63 0.4×	128 0.8×	99 1.1×	38 0.6×	31	574
Guilin Chen China	14	171 0.6×	44 0.3×	95 0.6×	58 0.7×	44 0.7×	36	434
Alan R. Olzinski United States	15	238 0.9×	43 0.3×	115 0.8×	148 1.7×	72 1.1×	19	680
Tianhong Peng China	12	270 1.0×	68 0.4×	158 1.0×	31 0.4×	21 0.3×	22	485
Christoph Brenner Austria	16	373 1.4×	74 0.5×	127 0.8×	177 2.0×	57 0.9×	40	819
Suvi E. Heinonen Finland	12	221 0.8×	59 0.4×	77 0.5×	110 1.3×	38 0.6×	24	559
Hendrika A. B. Peters Netherlands	13	246 0.9×	41 0.3×	119 0.8×	56 0.6×	25 0.4×	27	502
Lingling Shu China	14	274 1.0×	119 0.7×	125 0.8×	40 0.5×	9 0.1×	35	596
Yi Yan China	13	238 0.9×	38 0.2×	97 0.6×	96 1.1×	24 0.4×	27	457

Countries citing papers authored by C Wang

Since Specialization

Citations

This map shows the geographic impact of C Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Wang more than expected).

Fields of papers citing papers by C Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Wang. The network helps show where C Wang may publish in the future.

Co-authorship network of co-authors of C Wang

This figure shows the co-authorship network connecting the top 25 collaborators of C Wang. A scholar is included among the top collaborators of C Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Wang. C Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Tingting, Qin Gao, C Wang, et al.. (2025). Targeting the cGAS-STING Pathway for Cancer Immunotherapy: From Small-Molecule Agonists to Advanced Nanomaterials. Molecular Pharmaceutics. 22(12). 7262–7284.

Erhardt, Erik B., Andrew R. Mayer, Henry C. Lin, et al.. (2025). The influence of intermittent hypercapnia on cerebrospinal fluid flow and clearance in Parkinson’s disease and healthy older adults. npj Parkinson s Disease. 11(1). 334–334. 1 indexed citations

Chen, Jiaoling, Ke Xue, Zhenlai Zhu, et al.. (2025). Tonsillar microbiota alterations contribute to immune responses in psoriasis by skewing aged neutrophils. British Journal of Dermatology. 193(2). 310–321.

Liu, Hongfu, Dongdong Zhou, Kai Zhang, et al.. (2024). Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer. Cell Death and Disease. 15(3). 187–187. 12 indexed citations

Kong, Jie, et al.. (2024). A dedicated in-beam PET system with a modular dual-head for radiotherapy imaging in HIMM. Journal of Instrumentation. 19(4). P04021–P04021. 2 indexed citations

Zhao, Rui, Xin Zhou, Zhiyuan Zhao, et al.. (2024). Farrerol Alleviates Cerebral Ischemia–Reperfusion Injury by Promoting Neuronal Survival and Reducing Neuroinflammation. Molecular Neurobiology. 61(9). 7239–7255. 8 indexed citations

Chen, Qiaoyu, C Wang, Binya Liu, et al.. (2023). The adverse effects of vitrification on mouse embryo development and metabolic phenotype in offspring. The FASEB Journal. 38(1). e23372–e23372. 1 indexed citations

Wang, C, Pei Liu, Yu Sun, et al.. (2023). Prognostic biomarker SYK and its correlation with immune infiltrates in glioma. Experimental and Therapeutic Medicine. 26(4). 499–499. 1 indexed citations

Wang, C, et al.. (2023). Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis. Journal of Orthopaedic Surgery and Research. 18(1). 487–487. 3 indexed citations

10.

Qiao, Huimin, et al.. (2023). Association between increased C-reactive protein and cardiovascular disease among patients with rectal cancer. Frontiers in Oncology. 13. 1287619–1287619. 2 indexed citations

11.

Sun, Yu, Ming Xu, C Wang, et al.. (2022). Low-molecular-weight fucoidan bidirectionally regulates lipid uptake and cholesterol efflux through the p38 MAPK phosphorylation. International Journal of Biological Macromolecules. 220. 371–384. 19 indexed citations

12.

Zhang, Zhaolong, Guoping Liu, Xiaolong Zhao, et al.. (2022). Primary balloon angioplasty for chronic occlusion of intracranial internal carotid artery: A case report. SHILAP Revista de lepidopterología. 5(4). 213–216. 1 indexed citations

13.

Xiang, Shao, et al.. (2020). [Risk factors and clinical features of hospital-associated venous thromboembolism].. PubMed. 100(20). 1539–1543. 1 indexed citations

14.

Su, Ming, Jingqiao Wang, C Wang, et al.. (2020). Correction: MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death and Differentiation. 28(1). 420–422. 5 indexed citations

15.

Yang, Sheng, et al.. (2016). A HSP60-targeting peptide for cell apoptosis imaging. Oncogenesis. 5(2). e201–e201. 15 indexed citations

16.

Chang, Guoqiang, Juan Wang, Han Zhang, et al.. (2014). CD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis via the regulation of ERK1/2. British Journal of Cancer. 110(4). 916–927. 37 indexed citations

17.

Su, Ming, Jianwei Wang, C Wang, et al.. (2014). MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death and Differentiation. 22(6). 986–999. 139 indexed citations

18.

Liu, Jing, C Wang, Jie Ni, et al.. (2013). Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovascular Research. 100(3). 450–460. 56 indexed citations

19.

Wang, C, Shuiyun Wang, Peng Zhao, et al.. (2012). MiR‐221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. Journal of Cellular Biochemistry. 113(6). 2040–2046. 61 indexed citations

20.

Zhou, Yu, Hong Chen, Xiaoli Ma, et al.. (2009). Fusion protein of adenovirus E4orf4 and human epidermal growth factor inhibits tumor cell growth. International Journal of Cancer. 125(5). 1186–1192. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact